News

Press Releases

Axenic™ Acquires IP of Q Surgical, Q Biotechnologies to Transform Global Market for Hand and Surface Hygiene

PLANO, TX — Axenic™ Health Solutions Inc. is proud to announce its acquisition of substantially all the assets and intellectual property formerly owned by the U.K-based entities, Q Surgical Technologies, Ltd. And Q Biotechnologies, Ltd. These acquisitions will allow Axenic to both globally expand and rapidly diversify an existing portfolio of infection prevention products originally designed for the defense and healthcare industries, and currently distributed to markets across EMEA, the United States and Asia under the brand name, Q Shield™. Following today’s announcement, Axenic will accelerate its plans to develop additional patentable hand and surface protectants to serve commercial environments in any industry, governments, nonprofits, and consumers anywhere in the world.

read more

Axenic™ Announces Positive Laboratory Test Results from Nelson Laboratories, LLC

PLANO, Texas — Axenic™ Health Solutions, Inc. announces laboratory test data, from industry respected Nelson Laboratories, LLC, (nelsonlabs.com) showing that its patent pending multi-SiQuat based Q Shield™ Hand had notable activity against several common pathogens in a series of “kill tests” consistent with the industry standard testing requirements. Testing showed that after 30 seconds of exposure to Q Shield Hand, there was a significant reduction in the presence of detectable pathogens tested – see Table 1 below for a summary of the results. “Kill testing” protocols dictate that testing is conducted to a maximum of 10 minutes. Although it should be noted that persistence testing was not part of this study, Q Shield Hand results also demonstrated no increase in the levels of the bacteria and fungi representative in this study after 10 minutes.

read more